MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
25.74
-0.02
-0.08%
After Hours: 25.74 0 0.00% 17:27 12/29 EST
OPEN
25.58
PREV CLOSE
25.76
HIGH
26.07
LOW
25.27
VOLUME
126.93K
TURNOVER
--
52 WEEK HIGH
29.80
52 WEEK LOW
11.51
MARKET CAP
1.67B
P/E (TTM)
-7.5068
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PHVS last week (1222-1226)?
Weekly Report · 22h ago
Why Pharvaris (PHVS) Is Up 13.3% After RAPIDe-3 Success And 2026 Deucrictibant Filing Plans
Simply Wall St · 12/23 03:22
Morgan Stanley Reaffirms Their Buy Rating on Pharvaris (PHVS)
TipRanks · 12/22 14:06
Weekly Report: what happened at PHVS last week (1215-1219)?
Weekly Report · 12/22 09:03
3 ‘Strong Buy’ Stocks to Buy Now, 12/15/2025, According to Top Analysts
TipRanks · 12/16 03:50
Pharvaris (PHVS) Is Down 5.7% After Pivotal RAPIDe-3 Deucrictibant Data And 2026 Filing Plan
Simply Wall St · 12/16 01:27
Pharvaris (PHVS) Receives a Buy from Morgan Stanley
TipRanks · 12/15 14:05
Weekly Report: what happened at PHVS last week (1208-1212)?
Weekly Report · 12/15 09:03
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.